Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
基本信息
- 批准号:7333882
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-29 至 2010-02-27
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAirAmino Acid MotifsAmoeba genusAnimal Disease ModelsBacteriaBacterial PneumoniaBiological AssayBiological ModelsBreathingCell modelCell physiologyCellsClinicalCommunitiesComplexCytosolDataDevelopmentDisease OutbreaksDrug Delivery SystemsEndoplasmic ReticulumEndosomesEnvironmentEnzymesF Box DomainFamilyFresh WaterGenesGenomeGoalsGram-Negative BacteriaHumanImmuneImmunofluorescence ImmunologicImmunoprecipitationIn VitroIncidenceIndividualInfectionInfection preventionLaboratoriesLegionellaLegionella pneumophilaLegionellosisLegionnaires&apos DiseaseLifeLysosomesMammalian CellMapsMicrobial BiofilmsModificationMolecularNatureNumbersParis, FrancePathogenicityPathway interactionsPhagocytesPhagocytosisPharmacologic SubstancePhiladelphiaPlayPneumoniaProcessProliferatingProteinsProteomicsProtozoaRecruitment ActivityRegulatory ElementRoleScreening procedureSite-Directed MutagenesisSterilization for infection controlSwimmingSymptomsSystemThinkingType IV Secretion System PathwayUbiquitinationVacuoleVesicleVirulenceWaterWorkaerosolizedantimicrobial drugbactericidecell typedayimmune functionlensmacrophagemulticatalytic endopeptidase complexmutantnovelpathogenprotein functionresearch studyresponseubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): To breach the human immune defenses, intracellular bacteria can enter, hide and replicate within the host immune cells as well as subvert their immunological functions. This work will characterize the molecular mechanisms that are responsible for this phenomenon, potentially leading to development of novel anti-microbial drug targets. The intracellular human pathogen Legionella pneumophila is the causative agent of the severe bacterial pneumonia known as Legionnaire's disease. Inhalation of aerosolized bacteria results in outbreaks of disease, which can be fatal in people with suppressed immune function. Legionella utilizes an arsenal of proteins injected in the host cell to assume control over various host processes and establish an intracellular replicative niche. The goal of this study is to elucidate the function(s) of a family of Legionella pneumophila proteins that are predicted to alter host cellular responses via subversion of the host ubiquitination regulatory networks. These effector proteins contain the eukaryotic F-box domain, which targets proteins for ubiquitination. Preliminary data showed that these F-box effectors are translocated into the cytosol of host cells during infection and associate with ubiquitinated proteins. Initially the goal of this study is to map the molecular determinant governing the interaction of the F-box effectors with ubiquitinated proteins and the SCF E3 ubiquitin ligase complex in mammalian cells utilizing immunofluorescence and immunoprecipitation analyses. In vitro ubiquitination assay will be used to determine the capacity of these bacterial F-box effectors to recruit and ubiquitinate target proteins utilizing host ubiquitin ligases. Tandem tag affinity purification and proteomics analysis of ubiquitinated proteins targeted for modification by the F- box effectors would identify potential host regulatory elements that are targeted by Legionella during infection. This study will use the clinical isolate strain Lp1 to create deletion mutant lacking the F-box effectors and investigate the contribution of these proteins to the capacity of Legionella to infect and replicate in host cells. The ability of these mutant strains to ubiquitinate target proteins identified by the proteomics screen will be assessed utilizing a cellular model of infection. This work will elucidate the molecular mechanism enabling the human pathogen Legionella pneumophila to subvert host cellular processes by taking control of the host ubiquitination machinery, potentially identifying common features of subversion utilized by other pathogens capable of exerting similar control, which can be targeted by pharmaceuticals to control or prevent infection.
描述(由申请人提供):为了破坏人体免疫防御,细胞内细菌可以进入宿主免疫细胞内,隐藏和复制,并破坏其免疫功能。这项工作将表征负责这种现象的分子机制,可能导致新的抗微生物药物靶点的开发。细胞内的人类病原体嗜肺军团菌是称为军团病的严重细菌性肺炎的病原体。吸入雾化细菌会导致疾病爆发,这对免疫功能受抑制的人来说可能是致命的。军团菌利用注入宿主细胞的蛋白质库来控制各种宿主过程并建立细胞内复制生态位。本研究的目的是阐明嗜肺军团菌蛋白家族的功能,这些蛋白被预测通过颠覆宿主泛素化调控网络来改变宿主细胞反应。这些效应蛋白含有真核生物的F-box结构域,其靶向蛋白进行泛素化。初步数据显示,这些F-box效应物在感染过程中易位到宿主细胞的胞质溶胶中,并与泛素化蛋白质结合。最初,本研究的目标是利用免疫荧光和免疫沉淀分析,映射的分子决定因素,在哺乳动物细胞中的F-box效应与泛素化蛋白和SCF E3泛素连接酶复合物的相互作用。体外泛素化测定将用于确定这些细菌F盒效应物利用宿主泛素连接酶募集和泛素化靶蛋白的能力。通过串联标签亲和纯化和蛋白质组学分析,靶向被F盒效应物修饰的泛素化蛋白质将鉴定在感染期间被军团菌靶向的潜在宿主调节元件。本研究将使用临床分离菌株Lp 1创建缺失F-box效应子的缺失突变体,并研究这些蛋白质对军团菌感染宿主细胞和在宿主细胞中复制的能力的贡献。将利用感染的细胞模型来评估这些突变株使通过蛋白质组学筛选鉴定的靶蛋白泛素化的能力。这项工作将阐明的分子机制,使人类病原体嗜肺军团菌通过控制宿主泛素化机制,颠覆宿主细胞过程,潜在地识别颠覆的共同特征,利用其他病原体能够发挥类似的控制,这可以有针对性的药物,以控制或预防感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stanimir Stefanov Ivanov其他文献
Stanimir Stefanov Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stanimir Stefanov Ivanov', 18)}}的其他基金
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10092094 - 财政年份:2019
- 资助金额:
$ 4.68万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10553242 - 财政年份:2019
- 资助金额:
$ 4.68万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10329977 - 财政年份:2019
- 资助金额:
$ 4.68万 - 项目类别:
Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
- 批准号:
7576736 - 财政年份:2008
- 资助金额:
$ 4.68万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 4.68万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 4.68万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 4.68万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 4.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 4.68万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




